Tigabu Kassa

Array ( [id] => 3923813 [patent_doc_number] => 05876917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Dendritic cell-specific antibodies and method for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/640733 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 9086 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876917.pdf [firstpage_image] =>[orig_patent_app_number] => 640733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4205829 [patent_doc_number] => 06027922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use' [patent_app_type] => 1 [patent_app_number] => 8/637669 [patent_app_country] => US [patent_app_date] => 1996-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 17122 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/027/06027922.pdf [firstpage_image] =>[orig_patent_app_number] => 637669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3873699 [patent_doc_number] => 05747271 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-A2/tyrosinase derived peptides, and methods for treating said individuals' [patent_app_type] => 1 [patent_app_number] => 8/636676 [patent_app_country] => US [patent_app_date] => 1996-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 20 [patent_no_of_words] => 3533 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747271.pdf [firstpage_image] =>[orig_patent_app_number] => 636676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349523 [patent_doc_number] => 06214789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products' [patent_app_type] => 1 [patent_app_number] => 8/626646 [patent_app_country] => US [patent_app_date] => 1996-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8723 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214789.pdf [firstpage_image] =>[orig_patent_app_number] => 626646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985104 [patent_doc_number] => 20020098194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'METHODS FOR INDUCING IMMUNITY' [patent_app_type] => new [patent_app_number] => 08/621725 [patent_app_country] => US [patent_app_date] => 1996-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5091 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098194.pdf [firstpage_image] =>[orig_patent_app_number] => 08621725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159520 [patent_doc_number] => 20020147314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'MUCOSAL VASCULAR ADDRESSINS AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 08/875849 [patent_app_country] => US [patent_app_date] => 1997-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29108 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147314.pdf [firstpage_image] =>[orig_patent_app_number] => 08875849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533767 [patent_doc_number] => 06488932 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Method for treating cancer by administering MAGE-derived peptides' [patent_app_type] => B1 [patent_app_number] => 08/571263 [patent_app_country] => US [patent_app_date] => 1995-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4425 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/488/06488932.pdf [firstpage_image] =>[orig_patent_app_number] => 08571263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777470 [patent_doc_number] => 05820856 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Modified TALL-104 cells to treat cancer' [patent_app_type] => 1 [patent_app_number] => 8/446814 [patent_app_country] => US [patent_app_date] => 1995-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 9565 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/820/05820856.pdf [firstpage_image] =>[orig_patent_app_number] => 446814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871691 [patent_doc_number] => 05824487 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Method for screening for targets for anti-inflammatory or anti-allergic agents' [patent_app_type] => 1 [patent_app_number] => 8/542686 [patent_app_country] => US [patent_app_date] => 1995-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 44 [patent_no_of_words] => 8884 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824487.pdf [firstpage_image] =>[orig_patent_app_number] => 542686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4342063 [patent_doc_number] => 06284476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals' [patent_app_type] => 1 [patent_app_number] => 8/540922 [patent_app_country] => US [patent_app_date] => 1995-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 6267 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284476.pdf [firstpage_image] =>[orig_patent_app_number] => 540922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935507 [patent_doc_number] => 05939526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/530569 [patent_app_country] => US [patent_app_date] => 1995-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 16183 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939526.pdf [firstpage_image] =>[orig_patent_app_number] => 530569 [rel_patent_id] =>[rel_patent_doc_number] =>)